Cargando…

Structures of HIV-1 Neutralizing Antibody 10E8 Delineate the Mechanistic Basis of Its Multi-Peak Behavior on Size-Exclusion Chromatography

Antibody 10E8 is capable of effectively neutralizing HIV through its recognition of the membrane-proximal external region (MPER), and a suitably optimized version of 10E8 might have utility in HIV therapy and prophylaxis. However, 10E8 displays a three-peak profile on size-exclusion chromatography (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Do Kwon, Young, Wang, Xiangchun E., Bender, Michael F., Yang, Rong, Li, Yile, McKee, Krisha, Rawi, Reda, O’Dell, Sijy, Schneck, Nicole A., Shaddeau, Andrew, Zhang, Baoshan, Arnold, Frank J., Connors, Mark, Doria-Rose, Nicole A., Kwong, Peter D., Lei, Q. Paula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293163/ https://www.ncbi.nlm.nih.gov/pubmed/34200826 http://dx.doi.org/10.3390/antib10020023

Ejemplares similares

Improved HIV-1 neutralization breadth and potency of V2-apex antibodies by in silico design
por: Holt, Graham T., et al.
Publicado: (2023)

Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen
por: Ou, Li, et al.
Publicado: (2020)

Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces
por: Lee, Myungjin, et al.
Publicado: (2021)

Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site
por: Banach, Bailey B., et al.
Publicado: (2023)

Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domain
por: Kwon, Young D., et al.
Publicado: (2023)

Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency
por: Zhang, Baoshan, et al.
Publicado: (2023)

Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry
por: Lai, Yen-Ting, et al.
Publicado: (2019)

Removal of variable domain N-linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies
por: Chuang, Gwo-Yu, et al.
Publicado: (2020)

Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing Antibody
por: Kwon, Young D., et al.
Publicado: (2018)

Peak-valley-peak pattern of histone modifications delineates active regulatory elements and their directionality
por: Pundhir, Sachin, et al.
Publicado: (2016)

Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity
por: Steinhardt, James J., et al.
Publicado: (2018)

Assessment of Crosslinkers between Peptide Antigen and Carrier Protein for Fusion Peptide-Directed Vaccines against HIV-1
por: Ou, Li, et al.
Publicado: (2022)

Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting
por: Doria-Rose, Nicole A., et al.
Publicado: (2017)

Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boosting
por: Cheng, Cheng, et al.
Publicado: (2019)

Mechanistic Insights Delineating the Role of Cholesterol in Epithelial Mesenchymal Transition and Drug Resistance in Cancer
por: Abdulla, Naaziyah, et al.
Publicado: (2021)

Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half life
por: Zhang, Baoshan, et al.
Publicado: (2022)

Soluble prefusion-closed HIV-envelope trimers with glycan-covered bases
por: Olia, Adam S., et al.
Publicado: (2023)

Rhesus Macaque B-Cell Responses to an HIV-1 Trimer Vaccine Revealed by Unbiased Longitudinal Repertoire Analysis
por: Dai, Kaifan, et al.
Publicado: (2015)

A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention
por: Kwon, Young D., et al.
Publicado: (2021)

Single-cell Analysis Technologies for Immuno-oncology Research: from Mechanistic Delineation to Biomarker Discovery
por: Bai, Zhiliang, et al.
Publicado: (2021)

A New Mechanistic Model for Viral Cross Protection and Superinfection Exclusion
por: Zhang, Xiao-Feng, et al.
Publicado: (2018)

Hard Exclusive Reactions
por: D'Hose, Nicole
Publicado: (2018)

Tyrosine O-sulfation proteoforms affect HIV-1 monoclonal antibody potency
por: Cai, Cindy X., et al.
Publicado: (2022)

Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site
por: Crooks, Ema T., et al.
Publicado: (2015)

Strategies in size-exclusion chromatography /
Publicado: (1996)

Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8
por: Soto, Cinque, et al.
Publicado: (2016)

Herpes simplex meningitis presenting as headache in pregnancy: A case report
por: Boedeker, David, et al.
Publicado: (2022)

Synapse too exclusive for CD148
por: LeBrasseur, Nicole
Publicado: (2003)

Liposome retention in size exclusion chromatography
por: Ruysschaert, Tristan, et al.
Publicado: (2005)

Chapter 5 Size-exclusion chromatography
por: Silberring, J., et al.
Publicado: (2004)

HIV-1 Vaccine-elicited Antibodies Reverted to Their Inferred Naive Germline Reveal Associations between Binding Affinity and in vivo Activation
por: Dai, Kaifan, et al.
Publicado: (2016)

Infant Understanding of Different Forms of Social Exclusion
por: Prendergast, Claire Nicole
Publicado: (2019)

Somatic Populations of PGT135–137 HIV-1-Neutralizing Antibodies Identified by 454 Pyrosequencing and Bioinformatics
por: Zhu, Jiang, et al.
Publicado: (2012)

Peak Plasma Levels of mtDNA Serve as a Predictive Biomarker for COVID-19 in-Hospital Mortality
por: Edinger, Fabian, et al.
Publicado: (2022)

Paediatric Inflammatory Bowel Disease: A Mechanistic Approach to Investigate Exclusive Enteral Nutrition Treatment
por: Nahidi, Lily, et al.
Publicado: (2014)

Accurate Prediction for Antibody Resistance of Clinical HIV-1 Isolates
por: Rawi, Reda, et al.
Publicado: (2019)

Major genomic mitochondrial lineages delineate early human expansions
por: Maca-Meyer, Nicole, et al.
Publicado: (2001)

Covering digital health applications in the public insurance system: how to foster innovation in patient care while mitigating financial risks—evidence from Germany
por: Groene, Nicole, et al.
Publicado: (2023)

A Deadenylase Assay by Size-Exclusion Chromatography
por: He, Guang-Jun, et al.
Publicado: (2012)

Peak Elbow Flexion Does Not Influence Peak Shoulder Distraction Force or Ball Velocity in NCAA Division I Softball Pitchers
por: Bordelon, Nicole, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2bhsfib1lgiqsam79a551k8jbj